CD33 Positive Acute Myelogenous Leukemia
2 clinical trials · Condition
◉ Watch CD33 Positive Acute Myelogenous Leukemia
| Record | Firm | Date |
|---|---|---|
| Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy (NCT02312037) | Pfizer |
Track CD33 Positive Acute Myelogenous Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.